» Articles » PMID: 21103857

[Stereotactic Radiosurgery and Fractionated Stereotactic Radiotherapy of Acoustic Neuromas]

Overview
Journal HNO
Date 2010 Nov 25
PMID 21103857
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Stereotactic radiosurgery (SRS) is a neurosurgical field that has become increasingly important in the treatment of acoustic neuromas. Radiosurgical treatment modalities include the Gamma knife, the linear accelerator (LINAC), and the CyberKnife. Gamma knife radiosurgery (GKRS) is still unsurpassed in terms of the spatial accuracy of radiation delivery and has been used for decades in acoustic neuromas (>18000 patients). In contrast to surgical resection, the goal of SRS is long-term prevention of tumour growth with preservation of neurological function. Radiation-induced neuropathies rarely occur. However, there are essential differences between SRS and fractionated stereotactic radiotherapy (FSR) in terms of both their radiobiological effects and their modes of application. SRS can be performed in an outpatient setting. Neuromas of up to 3 cm in diameter represent potential candidates for SRS or FSR. For larger tumours, cystic lesions and neuromas with brain stem compression, microsurgical resection in experienced neurosurgical centres is still the preferred option. SRS (and FSR) are possible options for patients with tumour progression after subtotal surgery or tumour recurrence, or for patients unable or unwilling to undergo surgery.

Citing Articles

[Schwannoma in the epipharynx: a rare differential diagnosis].

Meyer M, Anagiotos A, Luers J, Loser H, Wardelmann E, Beutner D HNO. 2012; 61(5):425-8.

PMID: 23241860 DOI: 10.1007/s00106-012-2583-1.


[Vestibular schwannoma. Part 2: therapy, prognosis, and rehabilitation].

Maier W, Hassepass F, Aschendorff A, Laszig R HNO. 2012; 60(10):927-35.

PMID: 23052241 DOI: 10.1007/s00106-012-2534-x.


Short-term outcomes of CyberKnife therapy for advanced high-risk tumors: A report of 160 cases.

Wang Y, Wang Y, Jiang P, Ma J, Qu Z, Wang X Exp Ther Med. 2012; 3(4):725-727.

PMID: 22969959 PMC: 3438800. DOI: 10.3892/etm.2012.451.


Clinical application of CyberKnife for high-risk central nervous system tumors: A clinical trial report of 60 cases.

Wang X, Wang Y, Jiang P, Ma J, Qu Z, Liu H Exp Ther Med. 2012; 3(1):105-108.

PMID: 22969853 PMC: 3438679. DOI: 10.3892/etm.2011.356.


[Value of different strategies in the treatment of vestibular schwannoma: therapeutic aspects and literature analysis].

Maier W, Grauvogel T, Laszig R, Ridder G HNO. 2011; 59(5):425-36.

PMID: 21505927 DOI: 10.1007/s00106-011-2302-3.

References
1.
Chan A, Black P, Ojemann R, Barker 2nd F, Kooy H, Lopes V . Stereotactic radiotherapy for vestibular schwannomas: favorable outcome with minimal toxicity. Neurosurgery. 2005; 57(1):60-70. DOI: 10.1227/01.neu.0000163091.12239.bb. View

2.
Luppino F, Grooters E, de Bruine F, Zwinderman A, van der Mey A . Volumetrical measurements in vestibular schwannoma, the influence of slice thickness and patient's repositioning. Otol Neurotol. 2006; 27(7):962-8. DOI: 10.1097/01.mao.0000235371.39998.a7. View

3.
Larson D, Flickinger J, Loeffler J . The radiobiology of radiosurgery. Int J Radiat Oncol Biol Phys. 1993; 25(3):557-61. DOI: 10.1016/0360-3016(93)90080-f. View

4.
Battaglia A, Mastrodimos B, Cueva R . Comparison of growth patterns of acoustic neuromas with and without radiosurgery. Otol Neurotol. 2006; 27(5):705-12. DOI: 10.1097/01.mao.0000226302.59198.87. View

5.
Wiegand D, Fickel V . Acoustic neuroma--the patient's perspective: subjective assessment of symptoms, diagnosis, therapy, and outcome in 541 patients. Laryngoscope. 1989; 99(2):179-87. DOI: 10.1288/00005537-198902000-00010. View